Precigen to participate in the 2022 wells fargo healthcare conference

Germantown, md. , sept. 1, 2022 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that helen sabzevari, phd, president and ceo of precigen, will participate in a fireside chat at the 2022 wells fargo healthcare conference in boston, massachusetts on wednesday, september 7, 2022 at 11:35 am et.
PGEN Ratings Summary
PGEN Quant Ranking